RICHARD ERIC DAVIS to NF-kappa B
This is a "connection" page, showing publications RICHARD ERIC DAVIS has written about NF-kappa B.
Connection Strength
0.569
-
Constitutive nuclear factor kappaB activity is required for survival of activated B cell-like diffuse large B cell lymphoma cells. J Exp Med. 2001 Dec 17; 194(12):1861-74.
Score: 0.125
-
Reciprocal leukemia-stroma VCAM-1/VLA-4-dependent activation of NF-?B mediates chemoresistance. Blood. 2014 Apr 24; 123(17):2691-702.
Score: 0.073
-
Inhibitors of the NF-kappaB activation pathway from Cryptocarya rugulosa. J Nat Prod. 2009 Mar 27; 72(3):336-9.
Score: 0.052
-
Casein kinase 1alpha governs antigen-receptor-induced NF-kappaB activation and human lymphoma cell survival. Nature. 2009 Mar 05; 458(7234):92-6.
Score: 0.051
-
Compensatory IKKalpha activation of classical NF-kappaB signaling during IKKbeta inhibition identified by an RNA interference sensitization screen. Proc Natl Acad Sci U S A. 2008 Dec 30; 105(52):20798-803.
Score: 0.051
-
Cooperative signaling through the signal transducer and activator of transcription 3 and nuclear factor-{kappa}B pathways in subtypes of diffuse large B-cell lymphoma. Blood. 2008 Apr 01; 111(7):3701-13.
Score: 0.048
-
Identification of N-(quinolin-8-yl)benzenesulfonamides as agents capable of down-regulating NFkappaB activity within two separate high-throughput screens of NFkappaB activation. Bioorg Med Chem Lett. 2008 Jan 01; 18(1):329-35.
Score: 0.047
-
Frequent engagement of the classical and alternative NF-kappaB pathways by diverse genetic abnormalities in multiple myeloma. Cancer Cell. 2007 Aug; 12(2):115-30.
Score: 0.046
-
The human B-cell lymphoma cell line RC-K8 has multiple genetic alterations that dysregulate the Rel/NF-kappaB signal transduction pathway. Oncogene. 2002 Dec 12; 21(57):8759-68.
Score: 0.034
-
Oncogenic CARD11 mutations in human diffuse large B cell lymphoma. Science. 2008 Mar 21; 319(5870):1676-9.
Score: 0.012
-
A loss-of-function RNA interference screen for molecular targets in cancer. Nature. 2006 May 04; 441(7089):106-10.
Score: 0.011
-
Small molecule inhibitors of IkappaB kinase are selectively toxic for subgroups of diffuse large B-cell lymphoma defined by gene expression profiling. Clin Cancer Res. 2005 Jan 01; 11(1):28-40.
Score: 0.010
-
MALT1 and the API2-MALT1 fusion act between CD40 and IKK and confer NF-kappa B-dependent proliferative advantage and resistance against FAS-induced cell death in B cells. Blood. 2005 Apr 01; 105(7):2891-9.
Score: 0.010